Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ligand Pharmaceuticals (LGND) Inventory Average (2016 - 2025)

Historic Inventory Average for Ligand Pharmaceuticals (LGND) over the last 15 years, with Q3 2025 value amounting to $13.7 million.

  • Ligand Pharmaceuticals' Inventory Average fell 2265.62% to $13.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.7 million, marking a year-over-year decrease of 2265.62%. This contributed to the annual value of $19.0 million for FY2024, which is 220.06% up from last year.
  • Ligand Pharmaceuticals' Inventory Average amounted to $13.7 million in Q3 2025, which was down 2265.62% from $15.1 million recorded in Q2 2025.
  • In the past 5 years, Ligand Pharmaceuticals' Inventory Average ranged from a high of $38.4 million in Q2 2021 and a low of $13.7 million during Q1 2023
  • Moreover, its 5-year median value for Inventory Average was $22.7 million (2024), whereas its average is $22.8 million.
  • In the last 5 years, Ligand Pharmaceuticals' Inventory Average skyrocketed by 59749.59% in 2021 and then crashed by 4842.27% in 2023.
  • Quarter analysis of 5 years shows Ligand Pharmaceuticals' Inventory Average stood at $30.2 million in 2021, then tumbled by 40.95% to $17.8 million in 2022, then soared by 38.58% to $24.7 million in 2023, then crashed by 37.49% to $15.4 million in 2024, then dropped by 11.23% to $13.7 million in 2025.
  • Its Inventory Average was $13.7 million in Q3 2025, compared to $15.1 million in Q2 2025 and $14.4 million in Q1 2025.